Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation
US6329384A · kind A · utility
11Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2000 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Mar 20, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination of endothelin antagonists and RAS inhibitor is described. The combination is suitable for controlling diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.